• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Taiwan Greater China Fund

Taiwan Greater China Fund

  1. Santalis Pharmaceuticals Initiates a Phase 2 Study of Mild, Moderate and Severe Atopic Dermatitis - Enrolls First Patient Into Its Australian Clinical Trial Site

    Santalis Pharmaceuticals Initiates a Phase 2 Study of Mild, Moderate and Severe Atopic Dermatitis - Enrolls First Patient Into Its Australian Clinical Trial Site

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.